CPhI Onsite Module Conferences 2012 Shanghai China

Published: 28-May-2012

26 - 27 June 2012
Conferences
Shanghai, China

This series of modular conferences is taking place alongside the CPhI China 2012 exhibition. The first day will include a module entitled pharma manufacturing in China. The second day will include four modules on export strategies and regulatory; developing biosimilars; API sourcing in China; and commercialising r&d

Organiser: CPhI Conferences

Trending Articles

  1. ASGCT Annual Meeting 2024 7-11 May, 2024 | Meeting | Portland, OR
  2. CPhI North America 7-9 May 2024 | Exhibition | Pennsylvania, US
  3. Cleanroom Conference UK 22–23 May 2024 | Exhibition | Birmingham, UK
  4. CPhI Worldwide 2011 <b>25 - 27 October 2011</b><br> Messe Frankfurt
  5. Lounges 23-25 April 2024 | Conference | Messe Karlsruhe, Germany

You may also like

Manufacturing

CPHI set to return to Milan, Italy in 2024

The world's largest pharmaceutical event is set to return to Milan, Italy in October 2024 and will see figures from all over the industry, spanning the entire supply chain
Manufacturing

Surging demand for Korean pharma in 2023 ahead of CPHI Korea

According to the 2023 CPHI Annual Survey, the Korean pharma industry has seen its "growth potential" increase by 7% as interest grows before the highly anticipated CPHI Korea opening
Manufacturing

CPhI to return to Queen Sirikit National Convention Centre in Bangkok

The event is expecting a record attendance of over 8,000, with a significant number coming from overseas. This represents a near doubling of visitors compared to 2022
Manufacturing

CPHI & PMEC China 2023 see surge from ingredients demand

To help service the expanding demand for pharmaceutical manufacturing, CPHI is co-located alongside PMEC
Regulatory

The big risk for US CDMOs

With many of the largest CDMOs now running at capacity, drug sponsors will need to focus on mitigating risk and building resiliency
Manufacturing

EU supply chain regulation: what will it mean for companies attending CPHI?

Ahead of her session on “Manufacturing Excellence” at CPHI Frankfurt (1–3 November), Elisabeth Stampa, President of Medicines for Europe, along with Adrian van den Hoven, Director General of Medicines for Europe, map out the impact of EU supply chain regulation on pharma companies in an exclusive article for Manufacturing Chemist
Manufacturing

DuPont highlights healthcare portfolio at CPhI Worldwide 2021

“As healthcare demands grow and change, we are investing in innovative products that will allow our customers the flexibility they need”
Subscribe now